Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CareDx (CDNA)
NASDAQ:CDNA
CareDx (CDNA) Stock Price & Analysis
700 Followers
CDNA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.80 - $16.15
Previous Close$14.78
Volume728.37K
Average Volume (3M)888.87K
Market Cap
$769.80M
Enterprise Value$530.87M
Total Cash (Recent Filing)$268.18M
Total Debt (Recent Filing)$29.25M
Price to Earnings (P/E)-4.3
Beta1.72
Next Earnings
Aug 01, 2024EPS Estimate
-$0.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.43
Shares Outstanding52,083,792
10 Day Avg. Volume1,154,043
30 Day Avg. Volume888,871
Standard Deviation0.21
R-Squared0.15
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)4.53
Price to Sales (P/S)9.96
Price to Cash Flow (P/CF)-23.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.79
Enterprise Value/Gross Profit2.53
Enterprise Value/Ebitda-6.90
Forecast
1Y Price Target
$15.67Price Target Upside6.02% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
CareDx News
PremiumCompany Announcements
CareDx Appoints John W. Hanna as New CEO and Board MemberBulls Say, Bears Say
Bulls Say
Financial HealthThe company's robust cash and investment position indicates it is well-prepared financially to support its ongoing operations and strategic initiatives.
Financial PerformanceCompany's recent increase in revenue guidance reflects a strong confidence in its continued business growth.
Market ExpansionThe rise in organ donations and transplants could lead to a higher demand for the company's post-transplant testing services, potentially expanding its market.
Bears Say
Financial GuidanceThe company acknowledges there are some sources of downside to its raised 2024 guidance.
ProfitabilityNet loss was $118.1M, or ($2.21) per share, significantly higher than the estimated loss of $22.2M.
Revenue PerformanceTotal revenue was $65.6M, representing a 20% year-over-year decline.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CDNA FAQ
What was CareDx’s price range in the past 12 months?
CareDx lowest stock price was $4.80 and its highest was $16.15 in the past 12 months.
What is CareDx’s market cap?
Currently, no data Available
When is CareDx’s upcoming earnings report date?
CareDx’s upcoming earnings report date is Aug 01, 2024 which is in 77 days.
How were CareDx’s earnings last quarter?
CareDx released its earnings results on May 09, 2024. The company reported -$0.32 earnings per share for the quarter, beating the consensus estimate of -$0.474 by $0.154.
Is CareDx overvalued?
According to Wall Street analysts CareDx’s price is currently Undervalued.
Does CareDx pay dividends?
CareDx does not currently pay dividends.
What is CareDx’s EPS estimate?
CareDx’s EPS estimate is -$0.42.
How many shares outstanding does CareDx have?
CareDx has 52,083,794 shares outstanding.
What happened to CareDx’s price movement after its last earnings report?
CareDx reported an EPS of -$0.32 in its last earnings report, beating expectations of -$0.474. Following the earnings report the stock price went up 34.087%.
Which hedge fund is a major shareholder of CareDx?
Among the largest hedge funds holding CareDx’s share is ARK Investment Management LLC. It holds CareDx’s shares valued at 62M.
---
CareDx Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.67 (6.02% Upside)
$15.67 (6.02% Upside)
Blogger Sentiment
Neutral
CDNA Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 1.3M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $70.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.2%
Last 30 Days ▼ 6.0%
Last 30 Days ▼ 6.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
77.21%
12-Months-Change
Fundamentals
Return on Equity
-54.18%
Trailing 12-Months
Asset Growth
-14.35%
Trailing 12-Months
Company Description
CareDx
CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.
---
CDNA Earnings Call
Q1 2024
0:00 / 0:00
---
CDNA Stock 12 Month Forecast
Average Price Target
$15.67
▲(6.02% Upside)
Technical Analysis
Best Analysts Covering CDNA
1 Year
1 Year Success Rate
2/5 ratings generated profit
1 Year Average Return
+16.62%
reiterated a buy rating 4 days ago
Copying Mason Carrico's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of +16.62% per trade.
---